Figure 2.
Effects of ex vivo allergen challenge on CD63, CD69, and CD25 expression in activated and non-activated basophils. Whole blood samples from stable-mildly symptomatic allergic asthma patients (n=3) were stimulated with their respective allergen (20ng/ml or 100 ng/ml) or anti-FcεRI cross-linking antibody 29C6 (100 ng/ml). Unstimulated controls were exposed to stimulation buffer only. (A) Percentage of CD63pos basophils in unstimulated controls, 20 ng/ml, and 100 ng/ml allergen and anti-FcεRI cross-linking antibody stimulated samples. (B, C) MFI of CD69 (B) and ΔMFI (MFI of test-MFI of FMO control) of CD25 (C) are shown on CD63neg (open symbols) and CD63pos basophils (closed symbols). (A-C) Patients 1, 2, and 3 are represented as circle, square, and triangle symbols, respectively. Data are shown as mean ± SEM and analyzed using one-way ordinary ANOVA tests, with Dunnett`s (A) or Bonferroni`s (B, C) multiple group comparison test. **P<0.01 and *P<0.05. ns, not significant.